Aclarion, Inc. (ACON) vs Enveric Biosciences, Inc. (ENVB)
A side-by-side comparison of Aclarion, Inc. and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACON
Aclarion, Inc.
$2.36HealthcareDelayed quote: Oct 6, 2026, 12:21 PM EDT
ENVB
Enveric Biosciences, Inc.
$1.48HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — ACON vs ENVB
growth of $100 · dividends reinvested · last 4yACON -100.0% (-94.7%/yr)ENVB -99.8% (-78.5%/yr)ENVB compounded faster over this window
Log scale — wide-divergence pair
ACON ENVB
ACON vs ENVB: by the numbers
- •ACON is the larger company ($7M vs $7M market cap).
- •Both run net losses; ENVB's is the smaller (0.00% vs -10978.48% net margin).
Metrics side by side
Valuation
| Metric | ACON | ENVB |
|---|---|---|
| P/S ratio | 81.20 | N/A |
| P/B ratio | 0.40 | 0.82 |
Profitability
| Metric | ACON | ENVB |
|---|---|---|
| Gross margin | -291.27% | 0.00% |
| Operating margin | -9312.55% | 0.00% |
| Net margin | -10978.48% | 0.00% |
| ROE | -54.09% | -108.00% |
| ROIC | -57.11% | -107.99% |
Growth (annualized)
| Metric | ACON | ENVB |
|---|---|---|
| Revenue CAGR (5Y) | 3.75% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.